A Clinical Study Evaluating the Preliminary Anti-tumor Efficacy and Safety of Hemay181

Clinical trial NCT07446816 · RECRUITING

Trial details

NCT number: NCT07446816
Sponsor: Ganzhou Hemay Pharmaceutical Co., Ltd
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumors

Start date: 2025-12-03
Primary completion: 2026-08-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.